Cipher Pharmaceuticals Inc. (TSX: DND), announced today that Larry Andrews, President and Chief Executive Officer, is presenting at the 9th Annual BIO Investor Forum, which is being held in San...

Cipher Pharmaceuticals Inc. (TSX: DND), announced today that Larry Andrews, President and Chief Executive Officer, is presenting at the Rodman & Renshaw Annual Global Investment Conference, which...

Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the three and six months ended June 30, 2010. Q2 2010 Summary --------------- - Net revenue...

- Second quarter financial results to be released July 28, 2010 - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, July 8 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND), will host a conference...

Cipher Pharmaceuticals Inc. (TSX: DND) today announced that it reached a cumulative sales milestone for Lipofen(R), the Company's fenofibrate product. Achieving this target triggers a US$1.0...

Cipher Pharmaceuticals Inc. (TSX: DND) today commented on the outcome of the appeal by Purdue Pharma Products L.P. of the decision of the United States District Court for the District of Delaware...

Cipher Pharmaceuticals Inc. (TSX: DND) today announced the U.S. Food and Drug Administration ("FDA") has approved CIP-TRAMADOL ER, the Company's extended-release tramadol product, for the...

Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the three months ended March 31, 2010. Q1 2010 Summary --------------- - Total revenue increased...

- First quarter financial results to be released April 23, 2010 - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, April 16 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND), will host a...

Cipher Pharmaceuticals Inc. (TSX: DND) today announced it will hold its Annual and Special Meeting of Shareholders on Thursday, April 22, 2010 at 4:30 p.m. ET. WHAT: ANNUAL AND SPECIAL MEETING OF...